Strategic Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$611K Sell
9,550
-10,126
-51% -$666K 0.13% 101
2026
Q1
$1.4M Sell
19,676
-181
-0.9% -$14.3K 0.23% 88
2025
Q4
$1.63M Buy
19,857
+2,333
+13% +$182K 0.26% 85
2025
Q3
$1.32M Sell
17,524
-307
-2% -$22.9K 0.21% 90
2025
Q2
$1.32M Sell
17,831
-1,421
-7% -$98.9K 0.26% 74
2025
Q1
$1.55M Sell
19,252
-305
-2% -$26.2K 0.3% 73
2024
Q4
$1.53M Sell
19,557
-3,349
-15% -$285K 0.28% 73
2024
Q3
$2.15M Buy
22,906
+599
+3% +$50.3K 0.4% 60
2024
Q2
$1.74M Buy
22,307
+3,199
+17% +$261K 0.34% 63
2024
Q1
$1.74M Hold
19,108
0.34% 70
2023
Q4
$1.48M Sell
19,108
-259
-1% -$18.1K 0.28% 79
2023
Q3
$1.32M Buy
+19,367
New +$1.41M 0.26% 80

Other funds holding GEHC

Strategic Advisors's GEHC Position: Q2 2026 in Review

Strategic Advisors reduced its GE HealthCare (GEHC) stake by 51% in Q2 2026, selling an estimated $666K and leaving 9,550 shares worth $611K. The position accounts for 0.13% of the portfolio, ranked #101.

Strategic Advisors first reported a position in GEHC in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.15M in Q3 2024. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Strategic Advisors held 9,550 shares of GE HealthCare worth $611K as of Q2 2026.
  • Strategic Advisors sold 10,126 GE HealthCare shares in Q2 2026, an estimated $666K.
  • GE HealthCare made up 0.13% of Strategic Advisors's portfolio in Q2 2026, its #101 holding.
  • Strategic Advisors first reported a position in GE HealthCare in Q3 2023 and has held it in 12 quarters since.
  • Strategic Advisors's GE HealthCare position peaked at $2.15M in Q3 2024.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Strategic Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.